Cargando…
pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation
BACKGROUND: RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated nanostructured lipid carriers (RIPL-NLCs) can facilitate selective drug delivery to hepsin (Hpn)-expressing cancer cells, but they exhibit low stability in the blood. Generally, biocompatible and nontoxic poly(ethylene glycol) surface modificati...
Autores principales: | Kim, Chang Hyun, Sa, Cheol-Ki, Goh, Min Su, Lee, Eun Seok, Kang, Tae Hoon, Yoon, Ho Yub, Battogtokh, Gantumur, Ko, Young Tag, Choi, Young Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204877/ https://www.ncbi.nlm.nih.gov/pubmed/30425481 http://dx.doi.org/10.2147/IJN.S184355 |
Ejemplares similares
-
RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells
por: Lee, Sang Gon, et al.
Publicado: (2018) -
Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution
por: Kim, Chang Hyun, et al.
Publicado: (2018) -
Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
por: Battogtokh, Gantumur, et al.
Publicado: (2018) -
Has “The Ceiling” Rendered the Readiness for Interprofessional Learning Scale (RIPLS) Outdated?
por: Torsvik, Malvin, et al.
Publicado: (2021) -
A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2022)